As of close of business last night, ENDRA Life Sciences Inc’s stock clocked out at $1.15, up 4.55% from its previous closing price of $1.10. In other words, the price has increased by $+0.0500 from its previous closing price. On the day, 599678 shares were traded.
Ratios:
To gain a deeper understanding of NDRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.68 and its Current Ratio is at 2.95. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.05.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 18 ’23 when Thornton Michael Milos bought 15,000 shares for $1.65 per share. The transaction valued at 24,750 led to the insider holds 34,139 shares of the business.
DIGIANDOMENICO ANTHONY bought 83,333 shares of NDRA for $100,000 on May 02 ’23. The Director now owns 102,434 shares after completing the transaction at $1.20 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NDRA now has a Market Capitalization of 12.69M and an Enterprise Value of 9.79M.
Stock Price History:
Over the past 52 weeks, NDRA has reached a high of $4.00, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is 1.2162, while the 200-Day Moving Average is calculated to be 1.2363.
Shares Statistics:
It appears that NDRA traded 123.08K shares on average per day over the past three months and 177.7k shares per day over the past ten days. A total of 11.04M shares are outstanding, with a floating share count of 10.83M. Insiders hold about 1.84% of the company’s shares, while institutions hold 1.19% stake in the company. Shares short for NDRA as of Feb 15, 2024 were 29.4k with a Short Ratio of 0.24, compared to 75.7k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.27% and a Short% of Float of 0.27%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.36 for the current quarter, with a high estimate of -$0.36 and a low estimate of -$0.36, while EPS last year was -$0.96. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.37 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$1.85 and -$1.85 for the fiscal current year, implying an average EPS of -$1.85. EPS for the following year is -$1.41, with 1 analysts recommending between -$1.41 and -$1.41.
